DiaSorin Market Cap

DiaSorin has a market cap or net worth of $5.79 billion as of July 2, 2025. Its market cap has increased by 4.58% in one year.

Market Cap

5.79B

Enterprise Value

6.59B

Revenue

1.31B

Ranking

n/a

PE Ratio

27.62

Stock Price

$107.68

Market Cap Chart

Since July 19, 2007, DiaSorin's market cap has increased from 854.91M to 5.79B, an increase of 577.74%. That is a compound annual growth rate of 11.24%.

Market Cap History

Date	Market Cap	% Change
Jul 2, 2025	5.79B	5.20%
Dec 30, 2024	5.51B	0.28%
Dec 29, 2023	5.49B	-26.18%
Dec 30, 2022	7.44B	-28.28%
Dec 30, 2021	10.37B	-9.11%
Dec 30, 2020	11.41B	61.14%
Dec 30, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 30, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Endo, Inc.	1.60B
Veradigm	798.20M
Elite Pharmaceuticals	781.98M
Nika Pharmaceuticals	708.22M
Tian'an Technology Group	628.15M
Glass House Brands	474.06M
American Oncology Network	449.82M
Northwest Biotherapeutics	349.09M

Market Cap Rankings